Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation

NCT03248037 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Fuchs' Endothelial Dystrophy
Bullous Keratopathy

Interventions

DRUG: Netarsudil
DRUG: Placebo

Sponsor

Cornea Research Foundation of America